Guantanamo.- The first days in the Guantanamo Province of vaccination campaign of infants with the new immunogen Pneumosil 10-valent, are reported to be successful with zero alarming events.
The attendance of the mothers of the expected children is calm and on time, which demonstrates the confidence of the population in the national health system and the medicines developed by Cuban scientists.
According to the experts, the new vaccine has no contraindications and has a very low risk of allergic reactions.
Studies in recent years show a predominance of pneumococci in 46 percent of cases of children with pneumonia, hence the importance of administering the 10-valent anti-pneumococcal vaccine Pneumosil.
The application of the new immunogen is the most effective measure to prevent invasive pneumococcal disease and with its inclusion in the vaccination schedule, 17 immunogens are available, of which 12 are produced in the country, to the pride of Cuban biotechnology.
